Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer

HIGHLIGHTS

  • who: Dhruba Deb from the DepartmentColumbia University, New York, NY, USA have published the article: Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer, in the Journal: Scientific Reports Scientific Reports
  • what: While the authors focused on NSCLC, the strategy can be expanded to other lung cancers and to the cancer of other organs.
  • how: Animal experiments were carried out independently at Danino lab and at

SUMMARY

    The authors established a strategy to identify combination treatments for genetically-distinct solid tumors by assessing their . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?